Nature's drug designer explores bio-inspired AI for pharmaceutical development. This shift from Big Pharma highlights AI's potential to accelerate the discovery of novel therapies by analyzing biological systems. It signals a new direction for chemical research, merging nature's complexity with advanced AI capabilities.
Opening Kapyn…